Janus Henderson Group plc 13D and 13G filings for Biohaven Pharmaceutical Holding Company Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:23 pm Purchase | 2024-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | JANUS HENDERSON GROUP PLC JHG | 6,982,425 6.900% | 756,032 (+12.14%) | Filing |
| 2024-11-14 3:06 pm Purchase | 2024-09-30 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | JANUS HENDERSON GROUP PLC JHG | 6,226,393 6.600% | 325,050 (+5.51%) | Filing |
| 2024-02-13 12:47 pm Purchase | 2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | JANUS HENDERSON GROUP PLC JHG | 5,901,343 7.400% | 1,338,832 (+29.34%) | Filing |
| 2023-02-13 10:14 am Purchase | 2022-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | JANUS HENDERSON GROUP PLC JHG | 4,562,511 6.700% | 4,562,511 (New Position) | Filing |